July 29 (Reuters) - Britain's GSK fell short of
quarterly expectations for profit on Wednesday, as sales of the
drugmaker's blockbuster shingles vaccine fell and stockpiling of
pain and lung medication tapered as countries eased lockdowns.
Turnover fell 3% to 7.62 billion pounds in the three months
ended June 30 on a constant currency basis, while adjusted
earnings stood at 19.2 pence per share, the company said. GSK
maintained its 2020 forecast.
Fourteen analysts on average expected second-quarter
adjusted earnings of 20.1 pence per share and sales of 7.72
billion pounds, according to a company-compiled consensus https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus.
(Reporting by Pushkala Aripaka, Ankur Banerjee in Bengaluru and
Ludwig Burger in Frankfurt; Editing by Bernard Orr)
Glaxosmithkline (GSK)
